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Human myxovirus resistance protein 1 (MxA) is an
interferon-induced dynamin-like GTPase that acts
as a cell-autonomous host restriction factor against
many viral pathogens including influenza viruses.
To study the molecular principles of its antiviral
activity, we determined the crystal structure of nucle-
otide-free MxA, which showed an extended three-
domain architecture. The central bundle signaling
element (BSE) connected the amino-terminal
GTPase domain with the stalk via two hinge regions.
MxA oligomerized in the crystal via the stalk and the
BSE, which in turn interacted with the stalk of
the neighboring monomer. We demonstrated that
the intra- and intermolecular domain interplay
between the BSE and stalk was essential for oligo-
merization and the antiviral function of MxA. Based
on these results, we propose a structural model for
the mechano-chemical coupling in ring-like MxA
oligomers as the principle mechanism for this unique
antiviral effector protein.
INTRODUCTION
Innate immunity plays an important role in early host defense
against invading viruses. Intracellular restriction factors can
severely limit transspecies transmission and spread of viral path-
ogens, as best illustrated in the case of zoonotic transmissions
of primate lentiviruses (reviewed in Wolf and Goff, 2008). In
mammals and other vertebrates, the interferon (IFN)-induced
myxovirus resistance (Mx) proteins are powerful antiviral factors
restricting a broad range of viruses, including influenza viruses
(Haller and Kochs, 2011). Recent evidence suggests that the
human MxA protein most probably provides a barrier against514 Immunity 35, 514–525, October 28, 2011 ª2011 Elsevier Inc.zoonotic introduction of influenza A viruses into the human pop-
ulation (Zimmermann et al., 2011).
The critical role of Mx proteins in antiviral protection has
previously been established in cell culture and animal model
systems, foremost the mouse. In contrast to wild-type mice
and rare inbred strains derived from them, most laboratory
strains carry deletions or nonsense mutations in the Mx1 gene
and, consequently, are highly susceptible to infection with path-
ogenic influenza and influenza-like viruses (Staeheli et al.,
1988). Mx gene expression depends on induction by type I
(alpha or beta) or type III (lambda) IFNs (Holzinger et al.,
2007), whereas the action of Mx proteins is IFN independent.
Thus, constitutive expression of recombinant mouse or human
Mx proteins protects transgenic laboratory mice against infec-
tion with Mx-sensitive viruses even in the absence of an IFN
response (Staeheli et al., 1986). A direct role of Mx proteins
was demonstrated by the fact that the Mx antiviral activity
can be neutralized in living cells by microinjection of specific
antibodies (Arnheiter and Haller, 1988). Besides its antiviral
function, MxA expression has also been linked to increased
sensitivity of cells to apoptotic stimuli (Mibayashi et al., 2002)
and to inhibition of tumor cell motility and invasiveness (Mush-
inski et al., 2009). Moreover, the mouse Mx1 protein has been
characterized as one of the few minor histocompatibility anti-
gens (Speiser et al., 1990).
Mx proteins are large GTPases and belong to a group of
IFN-induced GTPases involved in the control of intracellular
pathogens. These include the immunity-related p47 GTPases
and the guanylate-binding proteins (GBPs or p65 GTPases)
known to restrict the growth of invading bacteria and protozoa
(Hunn et al., 2011). Given their sequence similarity and biochem-
ical and structural properties, Mx proteins strongly resemble
the class of dynamin-like GTPases that mediate basic cellular
processes involving membrane remodeling (Low and Lo¨we,
2010; Haller and Kochs, 2011). Also, the human MxA GTPase
is closely associated with intracellular membranes, preferentially
of the endoplasmic reticulum-Golgi intermediate compartment
(Accola et al., 2002; Stertz et al., 2006), which is abused by
Table 1. Crystallographic Data Collection and Refinement Statistics
MxAa MxAD1-32a SeMet MxAa
Data Collection
Space group C2 C2 C2
Cell dimensions
a, b, c (A˚) 146.9, 137.6, 57.7 156.8, 134.0, 58.1 150.5, 138.1, 57.6
a, b, g () 90.0, 106.9, 90.0 90.0, 106.3, 90.0 90.0, 106.5, 90.0
Beamline BESSY MX14.1 BESSY MX14.1 SLS X06SA
Wavelength (A˚) 0.91841 0.91841 0.97960
Total reflectionsb 22,042 (3,152) 31,669 (5,141) 24,155 (1,819)
Unique reflectionsb 7,012 (1,076) 10,349 (1,699) 6,816 (532)
Resolution (A˚)b 31–3.50 (4.41–3.50)c 100–3.50 (4.15–3.50)d 50–5.60 (5.75–5.60)
Rsym
b 0.064 (0.341) 0.097 (0.595) 0.077 (0.712)
I/sIb 12.38 (4.30) 9.33 (2.25) 8.76 (2.01)
Completeness (%)b 50.3 (15.5) 70.6 (29.0) 98.8 (96.6)
Redundancy 3.14 (2.93) 3.06 (3.03) 3.54 (3.42)
Refinement
Resolution (A˚) 31–3.5 35–3.5
Rwork 0.306 0.262
Rfree 0.333 0.295
Number of atoms
Protein 4,642 4,507
Water 0 0
Rms deviations
Bond lengths (A˚) 0.006 0.015
Bond angles () 0.931 1.583
aMxA refers to the human MxA protein containing the quadruple point mutation YRGR440-443AAAA and deletion of amino acid residues 533–561.
Because of the better quality, the MxAD1-32 data were used for final refinement.
bNumbers in parentheses represent values from the highest resolution shell.
c Resolution limits along a*, b*, and c* are 4.5 A˚, 5.5 A˚, and 3.5 A˚, respectively.
dResolution limits along a*, b*, and c* are 4.0 A˚, 4.2 A˚, and 3.5 A˚, respectively.
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Structure of the Antiviral MxA GTPasemany viral pathogens as an intracellular replication site (Miller
and Krijnse-Locker, 2008).
Like most dynamin-like GTPases, Mx proteins are composed
of an amino-terminal (N-terminal) GTPase (G) domain, a central
middle domain (MD), and a carboxy-terminal (C-terminal)
GTPase effector domain (GED). Similarly to dynamin, human
MxA assembles into tetramers and shows low-affinity binding
of guanine nucleotides, concentration-dependent oligomeriza-
tion, and assembly-stimulated GTPase activation (Gao et al.,
2010). We previously determined the structure of the stalk of
MxA, which folds into a four-helical bundle composed of the
MD and the N-terminal part of the GED (Gao et al., 2010). This
stalk was found to mediate the assembly of MxA into tetramers
and higher-order oligomers via three distinct interfaces and two
loop regions. Based on the similar appearance of MxA and dyna-
min oligomers in electronmicroscopy images (Mears et al., 2007;
von der Malsburg et al., 2011) and based on the almost identical
localization of amino acid residues dictating oligomerization of
the stalks (Ramachandran et al., 2007; Gao et al., 2010), we sug-
gested that the overall architecture of the MxA and dynamin
oligomers is largely the same. To understand themolecular basis
of its antiviral function, we here describe the structure of full-length MxA and determine the role of the structural elements
for oligomerization, GTP hydrolysis, and antiviral activity.
RESULTS
Structure of the Full-Length MxA Monomer
Crystallization trials with full-length wild-type (WT) MxA did not
yield protein crystals. With electron microscopy, we previously
observed that WTMxA can reversibly assemble into regular, fila-
mentous, and ring-shaped, higher-order oligomers that can be
sedimented by ultracentrifugation (Kochs et al., 2002a). Muta-
tions in the three assembly interfaces in the stalk, however,
prevent formation of sedimentable oligomers and, concurrently,
interfere with the antiviral activity (Gao et al., 2010). We reasoned
that the higher-order oligomers formed by WT MxA might not
be compatible with crystal formation and therefore assayed
assembly-defective stalk mutants for crystallization. Indeed,
crystals of an MxA variant carrying four amino acid exchanges
in interface-3 (YRGR440-443AAAA) and a deletion of 29 amino
acids in the predicted substrate binding loop L4S (533-561)
(DL4S) were obtained, which anisotropically diffracted to a maxi-
mum resolution of 3.5 A˚ (Table 1). The structure was solved byImmunity 35, 514–525, October 28, 2011 ª2011 Elsevier Inc. 515
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Figure 1. Structure of the MxA Monomer
(A) Structure-based domain representation of
human MxA. B, BSE. The previous terminology
based on sequence alignments is indicated below.
(B) Ribbon-type representation of an MxA mono-
mer, colored as in (A), with individual domains and
the two hinges specified. N andC termini aswell as
secondary structure elements are labeled. The
unresolved truncated loop L4S in the stalk is indi-
cated by a dashed line. The invariant Pro340 link-
ing G domain and BSE (hinge 2) is shown as
spheres in cyan.
(C) Structural details of the BSE. The three-helical
bundle is shown in ribbon-type representation and
residues of the hydrophobic core of the BSE are
shown in ball-and-stick representation. G domain
and L1BS were removed for clarity.
See also Figure S1 and Table 1.
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Structure of the Antiviral MxA GTPasemolecular replacement with the structure of the MxA stalk (Gao
et al., 2010) and the nucleotide-free G domain of dynamin (Reu-
bold et al., 2005) as search models, and refined to an Rwork of
26.2% and an Rfree of 29.5% (Table 1). To verify the sequence
assignment, the positions of nine methionines were determined
by calculating an anomalous difference Fourier map from sele-
nomethione (SeMet)-substituted MxA crystals (see Figure S1A
available online). Even at this moderate resolution, side chain
density for a number of residues also in previously undefined
regions became apparent (Figures S1B–S1D). The model begins
at Tyr45 and ends at the final C-terminal residue of MxA, Gly662,
with four gaps in the G domain and one in the truncated loop L4S
in the stalk.
MxA appeared as an elongated molecule with a three-domain
architecture composed of the G domain, the bundle signaling
element (BSE), and the stalk (Figures 1A and 1B). Some parts
of the globular G domainwere only weakly defined in the electron
density. It consisted of a central b sheet surrounded by a helices
(Figure 1B). The two switch regions known to mediate nucleo-
tide-dependent changes were not visible in the electron density.
Also, the G4 and the cis- and trans-stabilizing loops, contributing
to dimerization of G domains in dynamin (Chappie et al., 2010),
were mostly invisible. The stalk was located at the opposing
end of the MxA molecule. It was built of an extended four-helical
bundle (a1S–a4S, where superscripts G, B, and S stand for G
domain, BSE, and stalk, respectively) and had an almost iden-
tical architecture to the isolated stalk of MxA (Figure 1B; Gao
et al., 2010). However, loop L2S, which is not visible in the free516 Immunity 35, 514–525, October 28, 2011 ª2011 Elsevier Inc.stalk structure, was fully resolved. It con-
tained the YRGR440-443AAAA mutation
required for crystallization.
Strikingly, the BSE formed an extended
structure in the center of the MxA mole-
cule (Figure 1B). It was composed of
three helices (a1B–a3B), which were de-
rived from widely dispersed sequence
regions of MxA and, consequently, were
not coinciding with the domain bound-
aries delineated from the primary se-
quence (Figure 1A). a2B and a3B formeda profound hydrophobic network (Figures 1C and S1E), whereas
a1B was only weakly associated with a2B and a3B via a few
hydrophobic interactions (Figures 1C and S1F). Interestingly,
Glu645 in a3B, whose mutation to arginine alters the antiviral
specificity of MxA (Zu¨rcher et al., 1992a; Kochs et al., 2002b),
was accessible to the solvent (Figure S1G). The overall architec-
ture of this domainwas very similar to the BSE of dynamin (Chap-
pie et al., 2009, 2010).
At the N terminus, the G domain was connected to helix a1B of
the BSE and at the C terminus to a2B via the invariant Pro340
(Figure 1B). Corresponding prolines in dynamin (Chappie et al.,
2010), bacterial dynamin-like protein (BDLP) (Low and Lo¨we,
2010), GBP1 (Prakash et al., 2000), atlastin1 (Byrnes and Son-
dermann, 2011; Bian et al., 2011), and Eps15 homology-domain
containing protein 2 (EHD2) (Daumke et al., 2007) have previ-
ously been suggested to act as a hinge (hinge 2 according to
Low and Lo¨we [2010]) to mediate conformational coupling of G
domain and stalk (Figures 2 and S2). Our structure revealed
that the BSE was connected to the stalk via an additional hinge
(hinge 1) composed of loop L1BS and L2BS (Figures 1B and 3A).
L1BS was in a stretched conformation and interacted loosely with
L2BS and a5S of the stalk (Figures 3A and S3A). Additionally, the
highly conserved Arg640 of a3B formed polar contacts with
Gly361 andAsp363 of L1BS and the invariant Glu632 in the center
of L2BS (Figures 3A and S3B). Hinge 1 was previously described
in BDLP, but not in GBP1, EHD2, and atlastin that do not have
a BSE-like structural element (Figure 2). Interestingly, a mutation
of Arg725 in the homologous hinge 1 of dynamin corresponding
AB
D E
C Figure 2. Structural Comparison of MxA with Other
Dynamin Superfamily Members
Structural comparison of MxA (A) with nucleotide-free
BDLP (PDB accession code 2J69) (B), nucleotide-free
GBP1 (1DG3) (C), GDP-bound atlastin1 (3Q5D) (D), and
EHD2 in the presence of a nonhydrolyzable ATP analog
(2QPT) (E). G domains are colored in orange, stalk-like
structures in green (derived from the middle domain) and
blue (derived from the GED), and the BSE in red. Prolines in
the hinge regions are shown as cyan spheres, and nucle-
otides are shown in purple. A separate BSE is apparent
only in MxA and BDLP, whereas a proline residue-con-
taining hinge region is found in all structures. See also
Figure S2.
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Structure of the Antiviral MxA GTPaseto Arg640 in MxA leads to reduced GTPase activity upon micro-
tubule association but increased endocytosis efficiency (Sever
et al., 1999), suggesting that stabilization of hinge 1 contributes
to the conformational coupling of the G domain and the stalk.
Furthermore, a mutation in hinge 1 of rat Mx2 was shown to
abolish the antiviral activity (Figure S3C; Johannes et al., 1997).
Hinge 1 Controls Oligomerization and the Antiviral
Activity of MxA
To investigate the function of hinge 1, oligomerization assays
were carried out. At protein concentrations >2 mg/ml, MxA
reversibly forms higher-order oligomers that can be sedimented
by ultracentrifugation (Gao et al., 2010). Guanine nucleotides
promote oligomerization, most probably by creating an addi-
tional nucleotide-dependent interface in the G domain, as sug-
gested for dynamin (Chappie et al., 2010). Accordingly, 50% of
WT MxA oligomerized in the absence of nucleotide, whereas
more than 90% was sedimented in the presence of a nonhydro-
lyzable GTP analog, guanosine 50-O-[gamma-thio]triphosphate
(GTPgS) (Figure 3B). Two mutants in hinge 1, E632A in L2BS
and R640A in a3B, did not oligomerize in the absence of nucleo-
tides. However, in the presence of GTPgS, E632A still oligomer-Immunity 35, 51ized to some degree whereas the R640A mutant
was completely in the supernatant (Figure 3B).
These data were further corroborated by gel
filtration and right angle light scattering (RALS)
analysis (Figure S3D), where WT MxA, in the
absence of nucleotide, showed a dimer-
tetramer equilibrium and mutants E632A and
R640A were mostly dimeric (Figure S3D), indi-
cating that an intact hinge 1 is important for the
native assembly of MxA oligomers.
Our previous analysis of stalk mutants indi-
cated that higher-order oligomerization of MxA
reduces the off-rate for GTP, which might
become rate-limiting in GTPase reactions at
high protein concentrations (Gao et al., 2010).
To test whether oligomerization mediated by
the hinge 1 region is also involved in this regula-
tion, GTPase activities of the hingemutants were
monitored at different protein concentrations via
multiple-turnover assays at saturating GTP
concentrations. WT MxA showed a cooperative
GTPase reaction with an estimated kmax of6 min1 (Figure 3C). The E632A mutant displayed a 5-fold
increase in maximal GTPase activity, whereas the R640A muta-
tion in the center of hinge 1 led to a dramatically accelerated GTP
turnover already at low protein concentrations. Thus, an intact
hinge 1 was required for higher-order oligomerization of MxA
and efficient control of the GTPase activity in solution, which
might avoid futile cycles of GTP hydrolysis in its ground state.
To investigate the role of hinge 1 for the antiviral activity of
MxA, the E632A and R640A mutants were tested in a La Crosse
Virus (LACV) infection assay (Kochs et al., 2002b; Reichelt et al.,
2004). As previously described, when WT MxA-expressing cells
were infected, the nucleoprotein N of LACV was sequestered
into perinuclear structures. Formation of these MxA-N aggre-
gates is considered to be the basis of the antiviral effect of
MxA against LACV (Reichelt et al., 2004). An assembly-defective
mutant carrying a deletion of the putative substrate binding loop
L4 MxA (DL4S) (von der Malsburg et al., 2011) was used as
a negative control and showed no redistribution (Figure 3D;
Gao et al., 2010). The E632A mutant in hinge 1 still relocalized
to granular structures and colocalized with LACV nucleoprotein
(Figure 3D). This finding might be explained by the fact that
this mutant was still able to form oligomers in the presence of4–525, October 28, 2011 ª2011 Elsevier Inc. 517
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Figure 3. Integrity of Hinge 1 Is Important for the Function of MxA
(A) Structure of hinge 1 connecting BSE and stalk, with selected residues shown in ball-and-stick representation.
(B) Sedimentation experiments for WT MxA and selected mutants in hinge 1 were carried out in the absence and presence of 1 mM GTPgS. P, pellet fraction;
S, supernatant.
(C) Protein-concentration-dependent GTPase activities with excess of GTP over protein of WT MxA (open circle) and hinge 1 mutants E632A (open triangle) and
R640A (closed circle) were determined at 150 mMNaCl. The mean of kobs calculated from two independent experiments is indicated with the error bars showing
the range of the two data points.
(D) Complex formation of MxA with the LACV nucleoprotein (N). Vero cells transfected with the indicated MxA constructs were infected with LACV for 16 hr and
then stained with antibodies specific for MxA (green) and LACV N (red). In the overlays, a nuclear staining via TO-PRO dye is shown in blue. A total of 99% of
the cells transfected withWTMxA containedMxA-N complexes, compared to 97% for E632A. No complex formation (0%)was observed for R640A (n = 100). The
DL4S mutant is shown as a negative control (Gao et al., 2010).
(E) Minireplicon assay for influenza A virus polymerase. 293T cells were transfected with plasmids encoding viral nucleoprotein (NP), the polymerase subunits,
and a reporter construct encoding firefly luciferase under the control of the viral promoter. Expression plasmids for the indicated MxA constructs and for Renilla
luciferase under a constitutive promoter were cotransfected. Twenty-four hours later, the activity of firefly luciferase wasmeasured and normalized to the activity
of Renilla luciferase. The values without MxA expression were set to 100%. Error bars and standard deviations are indicated (n = 3). Protein expression was
analyzed by immunoblotting with specific antibodies. Significance was calculated with Student’s t test (n = 3). n.s., not significant; **p% 0.01; ***p% 0.001.
See also Figure S3.
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AB
Figure 4. Structure of the MxA Oligomer
(A) Two views of the MxA oligomer represented by six MxA monomers, as seen in the crystals. Monomer 1 is colored as in Figure 1B. The interaction site of the
BSE in monomer 4 with the neighboring stalk of monomer 6 is indicated by a black box. In the upper panel, crystallographic 2-fold axes are indicated by dashed
lines. In the lower panel, putative G domain-G domain dimerization sites (G interfaces) are specified.
(B) Ribbon-type representation of the MxA dimer with a transparent surface, spanning 200 A˚. The crystallographic 2-fold axis across interface-2 is indicated by
a dashed line.
See also Figure S4.
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Structure of the Antiviral MxA GTPasenucleotide (Figure 3B). However, replacement of the central
Arg640 by an alanine led to a diffuse distribution of the protein
within the cell and the R640A mutant failed to sequester the viral
nucleoprotein (Figure 3D), highlighting the importance of hinge
region 1 for the antiviral activity.
MxA has been described as the key interferon-induced
effector protein against influenza A viruses that blocks an early
step of the viral replication (Pavlovic et al., 1992). To evaluate
the role of hinge 1 for the inhibition of viral gene expression, a
minireplicon reporter assay using the polymerase of a highly
pathogenic H5N1 influenza virus was performed (Gao et al.,
2010). In these experiments, WT MxA inhibited viral RNA poly-
merase by >70% whereas the MxA (DL4S) mutant was inactive
(Figure 3E). Mutations in hinge 1 completely abolished (R640A)or reduced (E632A) the inhibitory effect of MxA. Collectively,
these results showed that an intact hinge 1 was essential for
the antiviral function of MxA.
Self-Assembly of MxA and Its Importance for Antiviral
Activity
MxA monomers in the crystals assembled via the stalks in a
criss-cross pattern to form a linear stalk filament (Figure 4A; Fig-
ure S4A). This arrangement via three distinct interfaces was
almost identical to the previously reported assembly of the iso-
lated MxA stalks (rmsd of 0.6 A˚ for the Ca atoms of the stalk
dimers) (Gao et al., 2010). The symmetric interface-2 in the
center of the stalks mediated dimerization of MxA (Figure 4B),
whereas interface-1 and interface-3 facilitated contacts betweenImmunity 35, 514–525, October 28, 2011 ª2011 Elsevier Inc. 519
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Figure 5. BSE-Stalk Interactions Mediate Oligomerization and Antiviral Activity
(A) Intermolecular interactions between BSE and stalk of two parallel monomers (e.g., monomer 4 and 6 from Figure 4A). Residues involved in this interface are
shown in ball-and-stick representation.
(B) Sedimentation experiments for WT MxA and the indicated mutants were carried out as described in Figure 3B.
(C) Protein-concentration-dependent GTPase activities were determined as described in Figure 3C, with WTMxA (open circles) and the Q358A (open diamond),
D478A (open circle), and K503A (open triangle) point mutants.
(D) Complex formation of WT MxA and the indicated mutants with the LACV nucleoprotein was determined as described in Figure 3D. A total of 99% of the cells
transfected withWTMxA contained MxA-N complexes, compared to 94% for D478A. No complex formation (0%) was observed for Q358A and K503A (n = 100).
The DL4S mutant is shown as a negative control.
(E) Minireplicon assay for influenza A virus polymerase for WT MxA and the indicated mutants as described in Figure 3E.
See also Figure S5.
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Structure of the Antiviral MxA GTPaseMxA dimers and allowed the formation of stable tetramers as
well as higher-order oligomers (Figures S4B–S4D). In the full-
length structure, loop L2S was now identified as a structural
component of interface-3. It interacted with helix a4S and
possibly L4S of the stalk of an opposite, antiparallel MxA mono-
mer (Figure S4D), which might explain its role in stabilization of520 Immunity 35, 514–525, October 28, 2011 ª2011 Elsevier Inc.the MxA oligomer (Gao et al., 2010). Interestingly, a2B of the
BSE contacted the stalk of a neighboring parallel MxA monomer
via a number of polar interactions (Figures 4A, 5A, and S5A). In
particular, Glu467 and Asp478 in a2S interacted with Gln358 in
a2B and Arg654 in a3B, respectively, whereas Lys503 in a3S
formed hydrogen bonds with the peptide backbone of a3B. In
AB
Figure 6. Model of Ring-like MxA Oligomer
Suggests a Mechanism for the Mechano-Chemical
Coupling
(A) Construction of ring-like MxA oligomers, as indicated
for anMxA tetramer. The indicated 23 rotation around the
flat hydrophobic interface-1 leads to the formation of ring-
like MxA oligomers. The BSE-stalk interface via Lys503 is
maintained by a 35 rotation of the G domain and BSE
versus the stalk around hinge 1. This tetramer was used to
construct a model for a ring-like MxA oligomer.
(B) Model of ring-like MxA oligomer shown as space-filling
representation. The individual domains are colored as in
Figure 1A, except for the G domains, which are colored in
light orange. Two MxA dimers are individually highlighted
in magenta and gray. The MxA ring is composed of 16
constitutive dimers.
See also Figure S6 and Movie S1.
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Structure of the Antiviral MxA GTPasethe stalk filament, this interaction took place at the opposite side
compared to the central stalk-stalk interaction sites (Figure 4A).
In oligomerization assays, the Q358A and D478A mutants in
the BSE-stalk interface behaved similar to WT MxA (Figure 5B).
However, gel filtration combined with right angle light scattering
analysis showed that the Q358A mutant eluted preferentially as
dimer, whereas the D478A mutant behaved like wild-type MxA
(Figure S5B), indicating a minor contribution of D478A to the
stability of the oligomer. Strikingly, the K503A mutant in a3S
did not oligomerize in the absence of nucleotides, but addition
of GTPgS rescued oligomerization (Figures 5B and S5B). These
data indicated that the MxA oligomer was stabilized not only by
stalk-stalk interactions, but additionally via contacts between
the stalk and the BSE of neighboring molecule.
In protein-concentration-dependent GTPase assays, the
Q358A and D478A mutants in the BSE-stalk interface showed
a 2- to 3-fold increased activity at higher protein concentrations
when compared to the wild-type, whereas the K503A mutant
had an even 5-fold increased GTPase rate (Figure 5C), confirm-
ing the central function of Lys503 in this BSE-stalk interface. We
recently showed that mutations interfering with tetramerization
of MxA display increased GTPase rates, possibly by overcoming
mobility restrictions in the rigid structure of the MxA tetramer
(Gao et al., 2010). Increased flexibility of the G domains might
then promote G domain dimerization in solution, leading to
increased GTPase rates. Consequently, our data indicated an
auto-inhibitory function of the BSE-stalk interface for theGTPase
activity of MxA.
In antiviral activity assays against LACV, both the Q358A and
the K503A mutants in the BSE-stalk interface showed a diffuse
cellular distribution, comparable to MxA(DL4S), suggesting a
requirement of the BSE-mediated stalk interactions for the anti-Immunity 35, 51viral activity. In agreement with our oligomeriza-
tion and RALS data, mutant D478A was still
capable of associating with LACV nucleoprotein
(Figure 5D). Likewise, the D478Amutant was still
active in the influenza minireplicon assay,
whereas the Q358A and K503A mutants lost
their antiviral function (Figure 5E). These results
indicated a central function of residue Lys503
and, additionally, Gln358 for the BSE-stalk inter-action and a critical role of this interface for the antiviral activity of
the MxA oligomer.
Structural Model of MxA Oligomeric Rings
In the crystals, the linearMxA filaments assembled via the stalks,
but theGdomains did not dimerize via the highly conserved inter-
face across the nucleotide binding site (Figure S6; Chappie et al.,
2010). In contrast to these linear oligomers, ring-like MxA oligo-
mers were observed around tubulated liposomes in electron
microscopy studies (Accola et al., 2002; von der Malsburg
et al., 2011).We previously suggested that flat hydrophobic inter-
face-1 allows rotation of dimeric MxA stalks assembled via inter-
face-2 (Figure 6A; Movie S1). By using this rotation and our full-
length MxA structure, we constructed ring-like MxA oligomers
with a diameter as described in the electron microscopy studies
(Figure 6B). The BSE was slightly adjusted to allow Lys503
contact the stalk. Compared to our previous model (Gao et al.,
2010), the G domains were located above the stalk not of the
same but of the neighboring molecule. This difference originated
from the introduction of the elongated BSE in our current model
whose structure was previously unknown. In the resulting model
of the MxA rings (Figure 6B), the stalks were forming the inner
layer andGdomains theouter layer of theoligomer. Thepredicted
substrate binding loop L4S pointed toward the inside of the ring
and could interact with viral or membranous target structures.
Most importantly, conformational changes of theG domain could
be transmitted to the stalk via the identified BSE-stalk interface.
DISCUSSION
Since the discovery of Mx resistance against influenza viruses
in mice (Lindenmann, 1964) and the cloning of the Mx gene4–525, October 28, 2011 ª2011 Elsevier Inc. 521
Immunity
Structure of the Antiviral MxA GTPase(Staeheli et al., 1986), much effort has been devoted to explore
the antiviral mechanism of Mx proteins (Haller and Kochs,
2011). The antiviral activity of MxA was shown to be dependent
on two essential features, namely GTP hydrolysis performed by
the G domain (Pitossi et al., 1993) and oligomerization mediated
by the MD and GED (Mele´n et al., 1992; Schwemmle et al., 1995;
Di Paolo et al., 1999; Gao et al., 2010).We recently demonstrated
that the MD and the N-terminal portion of the GED together form
a separate domain, the stalk of MxA, and elucidated the molec-
ular basis of oligomerization via this domain (Gao et al., 2010).
Interestingly, mutations or deletions in the MD and/or GED
were shown to influence GTPase activity (Schwemmle et al.,
1995; Gao et al., 2010), suggesting that a modular cross-talk
between G domain and stalk is required for antiviral effector
functions. However, because of the lack of structural data for
full-lengthMx and/or the related dynamin proteins, themolecular
basis of this cross-talk has remained elusive.
In our full-length MxA structure, we identified the BSE as the
third domain of MxA and demonstrated that it served an impor-
tant function in mediating oligomerization, as suggested by
previous biochemical studies (Di Paolo et al., 1999). The unique
architecture of the BSE involving elements from three widely
separated regions and its central localization in the MxA mole-
cule suggested a crucial role as transmitter of conformational
changes between the G domain and stalk. The two hinge regions
flanking the BSE appeared to be flexible andmight allow interdo-
main movements. Interestingly, some stability of hinge 1 was
essential for the assembly of theMxA oligomer, as demonstrated
by our mutagenesis studies. The extended shape of the full-
length MxA dimer (Figure 4B) resembled a low-resolution enve-
lope of a dimeric dynamin variant obtained by small angle
X-ray scattering (Kenniston and Lemmon, 2010), indicating a
similar architecture and mechanism.
How are domain movements in MxA initiated? For BDLP,
large-scale domain movements of the G domain versus the
stalk are triggered by GTP-dependent oligomerization on a lipid
template (Low and Lo¨we, 2010). This process involves dimeriza-
tion of G domains via an interface across the nucleotide binding
site (the G interface). Also in dynamin, nucleotide-dependent
dimerization of G domains via the G interface leads to stimulation
of the GTPase reaction (Chappie et al., 2010). The G interface is
highly conserved in the dynamin family, suggesting a similar
mechanism also for MxA (Figure 4A). However, in the linear
MxA filaments in our crystals, G domains of neighboring fila-
ments did not dimerize via the G interface. This implies that the
current nucleotide-free structure represents a functional state
of the MxA oligomer in which oligomerization is solely mediated
by stalk-stalk and BSE-stalk interactions. We envisage that
nucleotide-dependent dimerization of the G domains between
neighboring filaments induces a movement of the G domain
versus the stalk. It appears unlikely that this movement can be
transmitted to the stalk of the same MxA molecule via the two
flexible hinge regions. However, the identified interface between
the BSE and stalk of the neighboring molecule is a prime candi-
date for coupling conformational changes in the G domain with
an effector function in the stalk. Coupling of nucleotide hydro-
lysis to conformational changes in the neighboring molecule is
also observed in other molecular machines, for example in triple
AAA ATPases such as dynein (Carter et al., 2011). Furthermore,522 Immunity 35, 514–525, October 28, 2011 ª2011 Elsevier Inc.the identified BSE-stalk interface is important not only for the
function of MxA but also for the related dynamin protein (Faelber
et al., 2011).
The current MxA structure has profound implications for a
better understanding of the antiviral function of MxA. First, it
explains the phenotype of mutations shown previously to inter-
fere with antiviral activity. For example, Arg633 in MxA is located
in hinge 1 between stalk and BSE. Amino acid substitutions
at the corresponding residue in rat Mx2 were shown to abolish
antiviral activity (Johannes et al., 1997), presumably by disrupt-
ing necessary contacts between BSE and stalk. Likewise, a
mutation of Glu645 to arginine in the BSE was reported to alter
the antiviral specificity of MxA without affecting its GTPase
activity (Zu¨rcher et al., 1992a; Kochs et al., 2002b). According
to our model, Glu645 is located in a3B and is accessible for
potential interaction partners. This region has also been shown
to contain a nuclear localization sequence in murine Mx1
(Zu¨rcher et al., 1992b) that might interact with the nuclear trans-
location machinery.
Second, the MxA structure suggests a molecular model for
MxA action. Experimental evidence points to a direct interaction
of MxA with viral nucleocapsids. In negative-strand RNA viruses,
they represent ribonucleoprotein complexes that consist of the
viral genomic RNA associated with the viral nucleoprotein and
the viral polymerase. MxA was shown to bind to the nucleopro-
tein N of LACV and to form intracellular MxA-N complexes
(Kochs et al., 2002b), leading to depletion of N from viral replica-
tion sites (Reichelt et al., 2004). A physical interaction of MxA
with the viral nucleoprotein NP was also demonstrated for influ-
enza A viruses (Turan et al., 2004) and the closely related
Thogoto virus (Kochs and Haller, 1999). Finally, interaction with
NP is suggested by the fact that the viral NP determines the rela-
tive Mx sensitivities of avian versus human influenza A virus
strains (Zimmermann et al., 2011). We propose that the MxA
oligomeric rings represent antiviral molecular machines that
oligomerize around the viral nucleocapsid structure. Conforma-
tional changes upon GTP binding and/or hydrolysis might then
lead to disintegration of the infecting nucleocapsids. It is con-
ceivable that additional host cell factors are involved and may
modulate the antiviral activity and specificity (Zu¨rcher et al.,
1992b; Engelhardt et al., 2001;Wisskirchen et al., 2011). Besides
negative-strand RNA viruses, Mx proteins are able to inhibit a
range of additional viruses, among them double-stranded RNA
viruses or some DNA viruses (Mundt, 2007; Netherton et al.,
2009). In each instance, the same basic inhibitory mechanism
may apply, because the Mx block generally occurs early in the
viral life cycle, is affected by the sameMx-inactivatingmutations,
and is linked to the recruitment of the Mx GTPase to the viral
replication sites. Also, human MxA was reported to inhibit the
amplification of a Semliki Forest virus-based replicon in the
absence of viral structural proteins (Landis et al., 1998). It will
be interesting to unravel the common denominator of Mx sensi-
tivity in these highly divergent viruses.
The present crystal structure of MxA and the identification of
the oligomerization mechanism provide a molecular framework
to understand the antiviral function of MxA. Importantly, the
identification of the BSE-stalk interface and hinge 1 as crucial
structural elements not only sheds light on the molecular mech-
anism of the mechano-chemical coupling during the antiviral
Immunity
Structure of the Antiviral MxA GTPaseaction of Mx GTPases but also yields functional insights into the
molecular mechanisms of the related dynamins.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Human MxA constructs including or excluding the N-terminal 32 residues
(MxA or MxAD1-32) carrying the YRGR440-443AAAA mutation in loop L2S
and a deletion of amino acids 533–561 (loop L4S) and the SeMet-substituted
variant were prepared as described (Gao et al., 2010).
Crystallization and Structure Determination
Crystallization trials by the sitting-drop vapor-diffusion method were per-
formed at 20C. 1 ml of MxA or MxAD1-32 at a concentration of 10–20 mg/ml
were mixed with an equal volume of reservoir solution containing 7%
PEG3350, 100 mM HEPES (pH 7.6), 80 mM NaCl, 2.5% 2-methyl-2,4-pentan-
diol (MPD), and 5% glycerol. Crystals appeared after 2 days and reached their
final size (0.2 mm 3 0.2 mm 3 0.8 mm) within 5 days. Crystals of the SeMet
protein (which contained the N-terminal 32 residues) were obtained in 5%
PEG 3350, 100 mM HEPES (pH 7.5), 80 mM NaCl, 2%MPD, and 2% ethylene
glycol. For flash-cooling of the crystals in liquid nitrogen, a cryo-solution con-
taining 4% PEG3350, 60 mM HEPES (pH 7.6), 150 mM NaCl, 1 mM DTT, 2%
MPD, 3% glycerol, and 10% PEG200 was used for native humanMxA crystals
and 3% PEG3350, 60 mM HEPES (pH 7.5), 150 mM MgCl2, 1 mM DTT, 2%
MPD, and 11% ethylene glycol was used for SeMet-substituted MxA. Native
data sets for both constructs were collected from single crystals on beamline
MX14.1 at BESSY and processed and scaled with the XDS program suite
(Kabsch, 2010) and the Diffraction Anisotropy Server (Strong et al., 2006).
The phase problem was solved by molecular replacement by Phaser (McCoy
et al., 2007), with the human MxA stalk (Gao et al., 2010) and the nucleotide-
free rat dynamin-1 G domain (Reubold et al., 2005) as search models. Addi-
tional electron density of the C-terminal helix of the GED and three loops not
present in the searchmodels, namely L1BS, L2S, and L2BS, was clearly discern-
able (Figures S1B–S1D). Model building was done with COOT (Emsley and
Cowtan, 2004). Refinement was carried out with CNS employing a deformable
elastic network (DEN) (Schro¨der et al., 2010). A homology model of the MxA G
domain was calculated based on the nucleotide-free rat G domain of dynamin
with the SWISS-MODEL server (Guex and Peitsch, 1997) and was used,
together with the stalk structure of human MxA, to set up DEN restraints.
The G domain was less well defined in the electron density than the stalk
and theBSE because it was only loosely stabilized by crystal contacts (see Fig-
ure S6). For both MxA and MxAD1-32, electron density could be modeled from
residue 45. Because of the better quality, data of MxAD1-32 were used for the
final refinement (Table 1). To verify the sequence of the low-resolution struc-
ture, a data set of a SeMet-substituted crystal was collected at peak wave-
length on beamline X06SA at the Swiss Light Source (SLS). An anomalous
difference Fourier map was calculated in CCP4 (CCP4, 1994) with the phases
of the refined model. Eight out of nine selenium atoms in the stalk and one out
of three in the G domain were used to confirm the sequence (Figure S1A). The
final model has an excellent geometry at the given resolution, with 87.8% of all
residues in the most favored region and 0.2% of the residues in the disallowed
region of the Ramachandran plot, as determined by PROCHECK (Laskowski
et al., 1993). Figures were prepared with PyMOL (http://www.pymol.org).
Right Angle Light Scattering
A coupled RALS-refractive index detector (Malvern) was connected in line to
an analytical gel filtration column Superdex200 10/300 to determine absolute
molecular masses of the applied proteins. Data were analyzed with the
provided software. The running buffer contained 20 mM HEPES (pH 7.5),
400 mM NaCl, 2 mM MgCl2, and 2 mM DTT. For each protein sample,
100 ml of a 2 mg/ml solution was applied.
Oligomerization Assay
Oligomerization assays were carried out at 2.3 mg/ml (30 mM) full-length
protein in the absence and presence of 1 mM GTPgS. Samples were incu-
bated at room temperature for 10 min in a buffer containing 20 mM HEPES
(pH 7.5), 300 mM NaCl, and 2 mM MgCl2. After ultracentrifugation at200,000 3 g, 25C for 10 min, equivalent amounts of supernatant and pellet
were loaded on SDS-PAGE. Results shown are representative for two inde-
pendent experiments.GTP Hydrolysis Assay
GTPase activities of human MxA and the indicated mutants were determined
at 37C in 50 mMHEPES (pH 7.5), 150 mMNaCl, 5 mM KCl, and 5 mMMgCl2,
with different MxA concentrations. Saturating concentrations of GTP were
employed for each reaction. Reactions were initiated by the addition of protein
to the final reaction solution. At different time points, reaction aliquots were
20-fold diluted in GTPase buffer and quickly transferred in liquid nitrogen.
Nucleotides in the samples were separated via a reversed-phase Hypersil
ODS-2 C18 column (2503 4 mm), with 10 mM tetrabutylammonium bromide,
100 mM potassium phosphate (pH 6.5), and 7.5% acetonitrile as running
buffer, where denatured proteins were adsorbed at a C18 guard column.
Nucleotides were detected by absorption at 254 nm and quantified by integra-
tion of the corresponding peaks. Rates derived from a linear fit to the initial
rate of the reaction (<40% GTP hydrolyzed) were plotted against the protein
concentrations.Cells and Viruses
Human embryonic kidney cells (293T) and Vero cells were maintained in
Dulbecco’s modified Eagle medium with 10% fetal calf serum. The original
LACV strain from Reichelt et al. (2004) was used.Influenza A Virus Minireplicon System
cDNAs of the viral polymerase subunits (PA, PB1, and PB2) and the viral nucle-
oprotein (NP) were derived from influenza A/Vietnam/1203/04 virus. 293T cells
in 12-well plates were transfected with Nanofectin (PAA). A total of 10 ng of the
three plasmids encoding the subunits of viral RNA polymerase and 100 ng for
NPwere cotransfected with 50 ng of plasmid pPOLI-Luc-RT carrying the firefly
luciferase reporter gene as described (Zimmermann et al., 2011). To measure
transfection efficiency, 25 ng of the Renilla luciferase-encoding plasmid
pRL-SV40-Rluc (Promega) was cotransfected. For MxA expression, 300 ng
of the Mx-encoding plasmids were cotransfected. The negative control lacked
the plasmid encoding NP. Cells were lysed 24 hr after transfection. Firefly and
Renilla luciferase activities were determined with the Dual Luciferase assay
(Promega).Immunoblot Analysis
Cell lysates were analyzed by SDS-PAGE and immunoblot probed with
monoclonal mouse antibody M143 directed against MxA (Flohr et al., 1999),
monoclonal mouse antibody directed against FLUAV NP (Serotec), mono-
clonal mouse antibody against b-tubulin (Sigma), and horseradish peroxi-
dase-conjugated secondary antibodies.Immunofluorescence Analysis
Vero cells were prepared and stained for MxA proteins and viral antigens by
indirect immunofluorescence as described previously (Reichelt et al., 2004).
MxA was detected with the monoclonal mouse antibody M143, LACV N
protein with a polyclonal rabbit antibody. TO-PRO-3 iodide (Invitrogen) was
used for nuclear staining. Alexa Fluor 555 (Invitrogen) and Alexa Fluor 488
(Invitrogen)-conjugated donkey secondary antibodies and a Leica TCS SP II
confocal microscope were used for the detection of the proteins.ACCESSION NUMBERS
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